Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 2
This trial was to see how well erlotinib (Tarceva) worked as a first treatment for advanced non small cell lung cancer that is ‘EGFR positive’.
Recruitment start: 1 August 2007
Recruitment end: 15 October 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Denis Talbot
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Oxford Radcliffe Hospitals NHS Trust
Roche
Last reviewed: 8 April 2014
CRUK internal database number: 3157
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
